Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market

Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: OTCMKTS:BAYRY NYSE:LLY NASDAQ:HCM Source Type: news